MiR-144-3p downregulates ARID1A and thus promotes cell proliferation, metastasis, and Sunitinib resistance in clear cell renal cell carcinoma [66], whereas miR-31 functions as an oncomir for ARID1A in cervical cancer [67]. The gene discussed is ARID1A; the disease is cervical carcinoma.